非支配株主に係る包括利益、全事業営業利益又は全事業営業損失（△） - ライフサイエンス事業
- 【期間】
| 年度 | 非支配株主に係る包括利益 | 全事業営業利益又は全事業営業損失（△） - ライフサイエンス事業 |
|---|
| 2013/03 | - | | 74.6億 | |
| 2013/06 | - | | 6.72億 | -91% |
| 2013/09 | - | | 18.6億 | +176.6% |
| 2013/12 | - | | 48.8億 | +162.3% |
| 2014/03 | - | | 56.1億 | +15% |
| 2014/06 | -5.85億 | | 4.84億 | -91.4% |
| 2014/09 | 8.67億 | 黒転 | 17億 | +251.4% |
| 2014/12 | 52.1億 | +500.7% | 31.3億 | +84.2% |
| 2015/03 | 104億 | +100.6% | 40.7億 | +30% |
| 2015/06 | 23.7億 | -77.3% | -1.73億 | 赤転 |
| 2015/09 | 15.3億 | -35.4% | 6.19億 | 黒転 |
| 2015/12 | 25.2億 | +64.5% | 18.1億 | +193.1% |
| 2016/03 | 20.1億 | -20.3% | 30.7億 | +69.1% |
| 2016/06 | -24.1億 | 赤転 | 2.24億 | -92.7% |
| 2016/09 | -17.3億 | 赤縮 | 7.33億 | +227.2% |
| 2016/12 | 40.7億 | 黒転 | 4.82億 | -34.2% |
| 2017/03 | 60.4億 | +48.6% | 21.5億 | +345.6% |
| 2017/06 | 23.7億 | -60.8% | 8.41億 | -60.8% |
| 2017/09 | 54.7億 | +130.5% | 13.9億 | +64.7% |
| 2017/12 | 89.5億 | +63.6% | 19.5億 | +40.7% |
| 2018/03 | 88.8億 | -0.8% | 19.4億 | -0.4% |
| 2018/06 | 11.2億 | -87.4% | 1.53億 | -92.1% |
| 2018/09 | 45.9億 | +309.6% | 6.77億 | +342.5% |
| 2018/12 | 51.2億 | +11.6% | 12.4億 | +83.6% |
| 2019/03 | 70.9億 | +38.3% | 13億 | +4.7% |
| 2019/06 | 10.3億 | -85.4% | 5.87億 | -54.9% |
| 2019/09 | 23.1億 | +124.3% | 13.1億 | +123.3% |
| 2019/12 | 60.2億 | +160.4% | 18.8億 | +43.4% |
| 2020/03 | 65.4億 | +8.6% | 16.3億 | -13.6% |
| 2020/06 | - | | - | |
| 2020/09 | - | | - | |
| 2020/12 | - | | - | |
| 2021/03 | - | | - | |
| 2021/06 | - | | - | |
| 2021/09 | - | | - | |
| 2021/12 | - | | - | |
| 2022/03 | - | | - | |
| 2022/06 | - | | - | |
| 2022/09 | - | | - | |
| 2022/12 | - | | - | |
| 2023/03 | - | | - | |
| 2023/06 | - | | - | |
| 2023/09 | - | | - | |
| 2023/12 | - | | - | |
| 2024/03 | - | | - | |
| 2024/06 | - | | - | |
| 2024/09 | - | | - | |
| 2024/12 | - | | - | |
| 2025/03 | - | | - | |
